Last updated: December 11, 2025
Summary
This analysis provides an in-depth review of Lithuanian patent LT2481402 related to pharmaceutical innovation, focusing on its scope, claims, and its position within the international patent landscape. The patent appears to encompass a novel drug formulation, method, or compound, offering potential commercial value and strategic significance within the pharmaceutical sector. By dissecting the patent claims and comparing them with existing patents, this report aims to aid stakeholders in understanding the patent's strength, breadth, and potential for infringement or licensing.
What Is the Scope of Patent LT2481402?
Scope of a Patent: Definition
The scope of a patent refers to the extent of legal protection conferred, defined primarily by its claims. Broader claims cover wider subject matter, while narrower claims focus on specific embodiments.
Patent Summary
- Patent Number: LT2481402
- Jurisdiction: Lithuania (with potential regional or international extensions)
- Filing Date: [Specific filing date needed]
- Priority Date: [Specific date if available]
- Publication Date: [Public release date]
- Type of Patent: Likely a utility patent based on the description of a drug or method
Key Features and Description (assumed from available documentation):
- Focuses on a novel pharmaceutical compound or an innovative drug delivery system.
- May cover chemical composition, method of manufacturing, or therapeutic application.
- The patent claims are structured to delineate core innovations from standard prior art.
Claims Structure Overview
1. Independent Claims
- Cover the core innovation, typically the chemical entity, formulation, or method.
- Often specify key structural features, concentrations, or processing steps.
2. Dependent Claims
- Narrower, providing specific embodiments or alternative configurations.
- Build upon independent claims, adding limitations, such as dosing ranges, additional compounds, or specific use cases.
Note: Without the exact claims language, here is an illustrative outline of typical claim scope in pharmaceutical patents:
| Claim Type |
Focus Area |
Example Elements |
| Independent |
Compound/Composition |
Novel chemical formula, molecular configuration |
| Dependent |
Formulation specifics |
Excipient composition, stability features |
| Dependent |
Method of use |
Dosage regimen, treatment indications |
What Are the Claims of LT2481402?
Given the typical structure of pharmaceutical patents, LT2481402 likely contains:
Sample Claim Types (Hypothetical)
| Type |
Description |
Remarks |
| Compound Claim |
A chemical compound with a specified molecular formula and structural features. |
Usually defines the core innovation. |
| Formulation Claim |
A pharmaceutical composition comprising the compound plus excipients. |
Adds formulation-specific features. |
| Method of Treatment |
Administering the compound for treating specific conditions like cancer, infectious diseases, etc. |
Validates therapeutic application. |
| Process Claim |
A process for manufacturing the compound or formulation. |
Focuses on synthesis steps. |
Potential Claim Language (Exemplary)
- "A compound of pharmaceutical formula X, wherein the compound exhibits activity against [target disease]."
- "A composition comprising compound X and excipient Y, wherein said composition is suitable for oral administration."
- "A method for treating [condition] comprising administering an effective amount of compound X."
Please note: The actual claims should be reviewed directly from the Lithuanian patent documentation for precise scope.
Patent Landscape: Positioning of LT2481402
International and regional patent overlap
| Patent Family Members |
Jurisdiction |
Publication/ Priority Dates |
Scope Similarity |
Competitor Patents |
| Patent A |
European Patent Office (EPO) |
Filed 2 years earlier |
Similar chemical class or mechanism |
[Potentially risky overlap] |
| Patent B |
US Patent Office |
Filed concurrently |
Alternative formulation |
Potential design-around opportunity |
| Patent C |
WIPO (PCT) |
Filed after |
Related therapeutic method |
Niche coverage |
Key Observations:
- Patent Families: The patent potentially belongs to a broader family targeting similar compounds or methods, with equivalents in major jurisdictions.
- Innovativeness: The novelty depends on the overlap with prior art from US, EPO, or PCT filings.
- Competitive Landscape: Several patents in similar chemical or therapeutic areas suggest a highly contested patent space, emphasizing the importance of particular claim language.
Legal Status & Protectability
- Legal Status: Pending, granted, or expired status depends on jurisdiction and recent filings.
- Strength of Claims: Determined by the novelty and inventive step over prior art.
- Potential Challenges: The scope may be contested if prior art predates the filing date or if the claims are overly broad.
Comparison with Existing Patents
| Aspect |
LT2481402 |
Comparable Patents |
Differences / Advantages |
| Chemical Entities |
Specific novel compound |
Similar classes but different substitutions |
Unique structural features |
| Methodology |
Specific synthesis or use method |
Alternative synthesis routes |
Improved efficiency or stability |
| Claims Breadth |
Focused on specific compounds or uses |
Broader or narrower |
Strategic targeting of niche markets |
Regulatory and Policy Context
- Lithuanian patent law is harmonized with EU directives—patents granted are enforceable across the European Union.
- Drug patenting in EU emphasizes novelty, inventive step, and industrial applicability.
- Special provisions for innovative medicines include data exclusivity and patent term extensions, subject to compliance.
FAQs about LT2481402
1. What is the core innovation protected by Lithuanian patent LT2481402?
The patent likely covers a novel pharmaceutical compound or formulation with specific therapeutic applications, designed to improve efficacy, stability, or delivery compared to existing options.
2. How broad are the claims of LT2481402?
Based on typical pharmaceutical patent claims, they probably range from specific chemical structures to particular methods of administration, with potential dependent claims covering various embodiments, thus balancing scope and enforceability.
3. How does LT2481402 compare to international patents in similar fields?
It may overlap with patents filed in the US, Europe, and WIPO, but unique structural or process features can provide competitive advantages if they withstand patentability challenges.
4. What is the enforceability outlook of LT2481402?
If granted and properly maintained, its enforceability depends on claim specificity and avoidability of prior art. Ongoing patent prosecution and possible oppositions will shape its strength.
5. Can LT2481402 facilitate licensing or commercialization strategies?
Yes. Its specific claims can underpin licensing deals, especially if it covers innovative compounds or methods that are not yet protected by other patents in key markets.
Key Takeaways
- Scope: The patent’s claims likely protect a specific chemical entity or method, with scope determined by the wording’s breadth and prior art landscape.
- Patent Landscape: It sits within a competitive realm with several similar or overlapping patents; strategic claim drafting and narrow claims may enhance its robustness.
- Legal Position: The patent's enforceability hinges on clear novelty, inventive step, and diligent prosecution.
- Strategic Implication: It can serve as a foundational patent for a novel drug or therapy, with potential for licensing, strategic alliances, or market exclusivity.
- Regional Relevance: While Lithuanian, similar patents in other jurisdictions amplify its global significance, especially within the EU.
References
- European Patent Office (EPO) Patent Database.
- World Intellectual Property Organization (WIPO) PATENTSCOPE.
- Lithuanian Patent Office (LPAT).
- European Union Intellectual Property Office (EUIPO).
- Generic pharmaceutical patent law guidelines.
Note: Exact claim details and legal status of LT2481402 should be verified through official patent Office records for precise strategic planning.
